Aliskiren Hemifumarate Patent Expiration

1. Tekturna patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5559111 NODEN PHARMA δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
Jul, 2018

(5 years ago)

US5559111

(Pediatric)

NODEN PHARMA δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
Jan, 2019

(5 years ago)

US8617595 NODEN PHARMA Galenic formulations of organic compounds
Feb, 2026

(1 year, 7 months from now)

US8617595

(Pediatric)

NODEN PHARMA Galenic formulations of organic compounds
Aug, 2026

(2 years from now)




Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 05, 2012

NCE-1 date: 06 March, 2011

Market Authorisation Date: 05 March, 2007

Treatment: Treatment of hypertension

Dosage: TABLET

How can I launch a generic of TEKTURNA before it's drug patent expiration?
More Information on Dosage

TEKTURNA family patents

Family Patents